Pillstats
Rx only · Solution/ Drops · Ophthalmic

Bromfenac Sodium

Brands: Bromfenac Ophthalmic Solution, 0.07% · Prolensa · Bromfenac Ophthalmic Solution · Bromfenac Sodium

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)19737
US makers6 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$9.17$18.34$27.52$36.69Dec 2025Apr 2026Jul 2026
$30.103
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4829641.4K1.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.4K
Rx · 2026 Q1
4.3K
Units dispensed
+1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bausch & Lomb Incorporatedunknown3SUPPLYING
Alembic Pharmaceuticals Limitedunknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Dr.Reddy's laboratories Limitedunknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
Bausch & Lomb Americas Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.